Market Overview

Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More

Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More
  • Featured stories in this weekend's Barron's offer a look at the prospects for a leading pharmaceutical, an overlooked banking bargain and more.
  • A CEO discusses how he plans to take on his company's larger sports apparel rival.
  • Also, check out eight stocks that have dividend staying power.

"Bristol-Myers Squibb: Blockbuster Drug Stock" by Sandra Ward suggests that the promise of Opdivo, the leading treatment among a new class of cancer-fighting drugs, could help lift shares of Bristol-Myers Squibb Co (NYSE: BMY). See why Barron's thinks Opdivo, which was recently approved by the FDA, potentially means $8 billion to $9 billion in annual sales for the company.

In "KeyCorp: An Overlooked Banking Bargain," Jack Hough takes a look at why the shares of Cleveland-based KeyCorp (NYSE: KEY) look appealing after the selloff in the banking sector. The article explains why this regional bank's takeover of First Niagara could prove more lucrative than investors expect, and why its stock could rise as much as 30 percent over the next year.

Bill Alpert's "Core-Mark Stock Looks Vulnerable" makes the case that shares of convenience-store distributor Core-Mark Holding Company, Inc. (NASDAQ: CORE) are too pricey, given rising competition for its clientele from the likes of Wal-Mart and the likelihood of waning profits from cigarette sales. See by Barron's predicts a drop of up to 25 percent in the share price.

Related Link: Barron's: Are Trump And Sanders Killing The Market?

The CEO spotlight is turned on Kevin Plank, founder of Under Armour Inc (NYSE: UA), this week in "Under Armour's CEO Plank Takes On Nike" by Crystal Kim. Plank says he is bent on beating Nike at the sports apparel game, according to Barron's. See why this former linebacker is teeing up in footwear and fitness apps, and why basketball champ Steph Curry could be Under Armour's Michael Jordan.

In David Englander's "Cubic Corp. and Esterline Are Poised to Rebound," discover how these transportation and aerospace systems companies have been hammered by earnings disappointments, but many opportunities for growth remain for both. Barron's recommended Cubic Corporation (NYSE: CUB) and Esterline Technologies Corporation (NYSE: ESL) last year. Do they still think shares are worth buying?

Also In This Week's Barron's...

  • Some picks from Hartford Core Equity's manager in overlooked companies with cutting-edge, life-changing products
  • Why Cisco Systems, Inc. (NASDAQ: CSCO) suddenly looks like a winner
  • Eight dividend-paying companies with sustainable payout growth and good chances for price appreciation
  • Why Viacom, Inc. (NASDAQ: VIAB) needs big changes
  • A look at the slowing revenue growth at LinkedIn Corp (NYSE: LNKD)

At the time of this writing, the author had no position in the mentioned equities.

Image Credit: Public Domain


Related Articles (CORE + BMY)

View Comments and Join the Discussion!

Posted-In: Barron's bristol-myers squibb Cisco SystemsEducation Top Stories Media Trading Ideas General Best of Benzinga